What You Should Know:

您应该知道：

– eClinical Solutions LLC, a provider of digital clinical software and services, announced that it has received a majority investment from GI Partners, a private investment firm.

。

– This investment highlights eClinical Solutions’ strong position as a trusted partner for life science organizations of all sizes seeking to accelerate research and advance therapeutic breakthroughs in an increasingly complex trial landscape.

–这项投资突显了eClinical Solutions作为各种规模的生命科学组织的可靠合作伙伴的强大地位，这些组织寻求在日益复杂的试验环境中加速研究并推进治疗突破。

GI Partners’ Commitment to Industry Leaders

GI合作伙伴对行业领导者的承诺

This investment reflects GI Partners’ continued dedication to supporting industry leaders in critical services sectors. eClinical Solutions’ elluminate Clinical Data Cloud® SaaS platform streamlines data flows, accelerates cycle times, and boosts productivity, future-proofing clinical trials for clients.

这项投资反映了GI合作伙伴继续致力于支持关键服务行业的行业领导者。eClinical Solutions的elluminate Clinical Data Cloud®SaaS平台简化了数据流，加快了周期，提高了生产力，为客户提供了经得起未来考验的临床试验。

The financial terms of the private transaction remain confidential..

私人交易的财务条款保密。。

eClinical Solutions: A Leader in Clinical Data Solutions

电子临床解决方案：临床数据解决方案的领导者

Founded in 2012 in the Boston metropolitan area, a major hub for pharma and biotech innovation, eClinical Solutions has consistently developed technology to address the market’s escalating clinical data challenges. The company is recognized as a leader in data infrastructure and analytics, working with 16 of the Top 50 biopharmaceutical companies to help them derive maximum value from their data using modern infrastructure..

eClinical Solutions于2012年在波士顿大都会区成立，该地区是制药和生物技术创新的主要中心，一直在开发技术以应对市场不断升级的临床数据挑战。该公司被公认为数据基础设施和分析领域的领导者，与前50家生物制药公司中的16家合作，帮助他们使用现代基础设施从数据中获得最大价值。。

Continued Support from Summit Partners and Founders

峰会合作伙伴和创始人的持续支持

Summit Partners, an investor in eClinical since 2020, will retain a minority stake in the company. Additionally, eClinical’s founders will maintain a significant equity position alongside GI Partners.

Summit Partners自2020年以来一直是eClinical的投资者，将保留该公司的少数股权。此外，eClinical的创始人将与GI Partners一起保持重要的股权地位。

“When we founded eClinical over a decade ago, clinical data volume and complexity were beginning to escalate rapidly. To improve trial efficiency and help pharmaceutical companies keep up with the mounting pressure to shorten timelines, we had a vision to create frictionless data flows enabled by cloud and digital platforms,” said Raj Indupuri, co-founder and CEO of eClinical Solutions, who will continue to lead the company along with the current management team.

“十多年前，当我们成立eClinical时，临床数据量和复杂性开始迅速升级。为了提高试验效率并帮助制药公司跟上不断增加的压力以缩短时间表，我们有一个愿景，即创建由云和数字平台支持的无摩擦数据流，”eClinical Solutions联合创始人兼首席执行官Raj Indupuri表示，他将继续领导公司以及当前的管理团队。

“A lot has changed over the years, but our mission hasn’t. We are helping our clients get treatments to patients faster by providing them with a data infrastructure and analytics foundation that powers critical efficiencies across the R&D lifecycle. GI’s support will help fuel the next phase of our company’s journey, as we look to deepen our product roadmap, extend embedded AI capabilities, and help drive future-ready trials.”.

“多年来，很多事情都发生了变化，但我们的使命没有变。我们为客户提供数据基础设施和分析基础，提高整个研发生命周期的关键效率，从而帮助客户更快地为患者提供治疗。GI 的支持将有助于推动公司下一阶段的发展，因为我们希望深化我们的产品路线图，扩展嵌入式人工智能功能，并帮助推动未来就绪的试验。